查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1836317

除顫器市場，按組件、按產品類型、按最終用戶、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Defibrillator Market, By Component, By Product Type, By End user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 366 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年除顫器市場規模價值 83.4567 億美元，2025 年至 2032 年的複合年成長率為 8.7%。

除顫器是一種醫療設備，旨在向心臟施加可控電擊，以恢復正常心跳。它用於危及生命的情況，例如心室顫動或無脈性室性心動過速（心臟電活動變得混亂或停止有效泵血）。除顫器透過胸壁向心臟發送高能量脈衝，可以重置心律，使其有機會恢復正常收縮。這些設備可以是手動的，由訓練有素的醫療專業人員使用，也可以是自動體外心臟去顫器（AED），供非專業人員在緊急情況下使用。

除顫器市場-市場動態

配備除顫器的救護車擴大緊急醫療服務，提高存活率

全球緊急醫療服務 (EMS) 的快速擴張在提高心臟驟停存活率方面發揮關鍵作用。無論城市還是農村地區，配備先進除顫技術的救護車的部署確保了患者在送往醫院之前能夠立即接受救治干預。心臟驟停的存活率高度依賴治療速度，每分鐘缺乏除顫都會大幅降低患者復原的機會。透過將除顫器整合到 EMS 車隊中，急救人員可以在關鍵的「黃金時間」內啟動治療，從而改善患者的預後。許多國家正在大力投資升級其 EMS 基礎設施。這不僅包括增加在役救護車數量，還包括確保每個單位都配備最先進的自動體外心臟去顫器 (AED) 或手動去顫器。這些設備對於難以獲得醫院服務的農村或偏遠地區尤其重要。

此外，政府和衛生組織正在對急救醫療服務人員進行廣泛的高級心臟生命支持 (ACLS) 方案培訓，使他們能夠有效操作除顫器並提高復甦成功率。智慧型除顫器與即時病患監護和無線資料傳輸的結合，進一步提升了急救醫療服務的能力。一些先進的型號可將患者心電圖資料直接傳輸到醫院急診科，使醫生能夠在患者抵達後立即做好干涉準備。這種連接確保了院前和院內護理之間的無縫交接，從而減少了治療延誤。因此，配備現代除顫系統的急救醫療服務不僅可以挽救生命，還可以降低心臟病患者長期併發症的風險。

例如，

2024年3月，英國國家醫療服務體系（NHS）推出了300輛配備先進手動去顫器和方便用戶使用型自動體外心臟去顫器（AED）的新型救護車。這項大規模升級是加強院前心臟急救護理的更廣泛計劃的一部分。該計劃特別著重於縮短心臟驟停時的干涉時間，因為如果不立即進行除顫，心臟驟停患者的存活率會迅速下降。

除顫器市場-細分分析：

全球除顫器市場根據組件、產品類型、最終用戶和地區進行細分。

根據組件類型，市場分為兩類：植入式心臟復律去顫器 (ICD) 和體外去顫器 (ED)。植入式心臟復律去顫器憑藉其在持續心律監測和對高風險心臟病患者進行自動救生干預方面的有效性，佔據市場主導地位。 ICD 廣泛應用於有心室顫動、心室性心搏過速病史或有較高心臟驟停風險的患者。 ICD 無需外部干預即可在體內釋放精確電擊，使其成為心臟病專家和醫療保健提供者的首選。設備微型化、電池壽命延長以及遠端監控的改進等技術進步，進一步增強了其在醫院和專業心臟護理中心的應用。心血管疾病發生率的上升、人們對預防性心臟護理意識的提高以及一些國家優惠的報銷政策也推動了對 ICD 的需求。隨著 ICD 的持續創新和臨床應用的不斷擴展，預計 ICD 將在預測期內保持市場領先地位。

根據最終用戶類型，市場分為四類：醫院、公共市場、替代護理市場和家庭醫療保健。醫院在市場中佔據主導地位，主要原因是其在處理心臟驟停病例和其他心血管急診方面發揮關鍵作用。醫院配備了先進的基礎設施、重症監護病房和技術嫻熟的醫療保健專業人員，確保了除顫器的有效使用。大量的患者湧入和需要心臟監測的手術數量的增加進一步刺激了這一領域的需求。醫院也採用最新的除顫技術，包括自動化和植入式設備，以改善病患的治療效果。政府在醫療基礎設施方面的措施和投資增強了其處理緊急情況的能力。此外，醫院通常是緊急情況下的第一個治療點，這使其成為可靠的最終用戶群。隨著全球心血管疾病病例持續上升，醫院將繼續成為除顫器應用的主要貢獻者。

除顫器市場-地理洞察

在 2024 年的預測期內，亞太地區將佔據全球除顫器市場的主導地位。

預計在 2024 年預測期內，亞太地區將在收入和市場成長方面主導全球除顫器市場。該地區的領導地位很大程度上得益於中國、印度、日本和韓國等國家心血管疾病盛行率的上升、醫療保健意識的提高以及醫療保健基礎設施的快速擴張。這些國家的醫院和專門的心臟護理中心擴大採用植入式心律轉復除顫器 (ICD) 和先進的體外除顫器 (ED) 來治療心臟驟停和其他危及生命的疾病。政府和私人醫療保健提供者在現代化緊急醫療服務方面的投資不斷增加，包括部署配備除顫器的救護車，大大提高了心臟護理的可及性和及時性。此外，城市中心大規模的公共除顫計畫以及人們對預防性心臟護理意識的提高正在推動市場擴張。微型設備、穿戴式除顫器和遠端監控系統等技術進步進一步推動了醫院、替代護理機構和家庭醫療保健機構的應用。

此外，亞太地區擁有龐大的患者群體、不斷成長的可支配收入以及政府對心血管疾病管理的支持性舉措，這些因素共同構成了對除顫器製造商極具吸引力的市場。預計這些因素將在整個預測期內維持該地區在全球市場的主導地位。

預計在 2024 年的預測期內，北美的除顫器市場複合年成長率最高。

據估計，在 2024 年的預測期內，北美在全球除顫器市場中將實現最高的年複合成長率(CAGR)。這一強勁成長得益於該地區完善的醫療基礎設施、對心臟護理的高度認知以及先進除顫技術的廣泛採用。尤其是美國和加拿大，這兩個國家對醫院、緊急醫療服務和家庭醫療保健解決方案的投資正在增加，這加速了對植入式心律轉復除顫器 (ICD) 和體外除顫器 (ED) 的需求。學校、機場、體育設施和工作場所的大規模公共除顫計畫進一步支持了這一成長，縮短了對心臟驟停的反應時間。自動和穿戴式除顫器、更長的電池壽命和遠端監控功能等技術進步也有助於提高醫院、替代護理機構和家庭醫療保健使用者的採用率。此外，優惠的報銷政策、心臟設備的保險覆蓋以及政府加強院前急救的舉措，正在鼓勵醫療服務提供者和消費者採用除顫解決方案。這些因素，加上心血管疾病盛行率的上升，使得北美在預測期內成為全球複合年成長率最快的市場。

除顫器市場-競爭格局：

全球除顫器市場競爭激烈，既有多家知名醫療器材製造商，也有專注於先進心臟護理解決方案的創新新創公司。各公司在技術創新、產品品質、地理分佈和策略夥伴關係方面展開競爭。競爭格局的特點是產品發布、合作、合併和收購頻繁，旨在加強市場地位和擴大區域影響力。主要參與者正在大力投資研發下一代除顫器，包括植入式心律轉復除顫器 (ICD)、穿戴式式除顫器、半自動和自動體外去顫器 (AED)。這些創新專注於小型化、更長的電池壽命、增強的患者監護、與行動應用程式的連接以及即時心電圖傳輸等功能。透過結合這些先進功能，製造商旨在提高用戶友善性和臨床療效，從而在擁擠的市場中脫穎而出。從地理來看，由於心血管疾病盛行率上升、醫療支出成長以及政府大力推行院前心臟救治，各大公司正在亞太、拉丁美洲和中東等新興市場拓展業務。與醫院、急救醫療服務 (EMS) 提供者和公共醫療服務項目建立策略合作夥伴關係，進一步提升了市場滲透率。

此外，競爭環境鼓勵定價策略、售後服務和培訓計劃，以維護客戶忠誠度並確保除顫設備的正確使用。 FDA、CE 和其他地區機構的監管合規性和批准也在塑造競爭格​​局方面發揮關鍵作用。

目錄

第 1 章：除顫器市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 除顫器市場片段（按組件）
    • 除顫器市場按產品類型細分
    • 除顫器市場片段（按最終用戶）
    • 除顫器市場（按國家/地區）
    • 除顫器市場按地區細分
  • 競爭洞察

第3章：除顫器主要市場趨勢

  • 除顫器市場促進因素
    • 市場促進因素的影響分析
  • 除顫器市場限制
    • 市場限制的影響分析
  • 除顫器市場機遇
  • 除顫器市場未來趨勢

第4章：除顫器產​​業研究

  • PESTEL分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：除顫器市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：除顫器市場格局

  • 2024年除顫器市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：除顫器市場-按組件

  • 概述
    • 按組件分類的細分市場佔有率分析
    • 植入式心臟復律去顫器（ICD）
    • 體外去顫器（ED）

第 8 章：除顫器市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 體外去顫器
    • 心臟復律去顫器
    • 手動 ED
    • 自動化 ED
    • 穿戴式心臟復律去顫器

第 9 章：除顫器市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院
    • 公共接取市場
    • 替代護理市場
    • 家庭醫療保健

第 10 章：除顫器市場 - 按地區

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美除顫器主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按組成部分）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲除顫器主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（按組成部分）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區（APAC）
    • 概述
    • 亞太地區除顫器主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（按組成部分）
    • 亞太地區市場規模及預測（依產品類型）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲除顫器主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按組成部分）
    • 拉丁美洲市場規模及預測（依產品類型）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲除顫器主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（按組件）
    • MEA 市場規模及預測（依產品類型）
    • MEA 市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 11 章：除顫器產​​業主要供應商分析

  • 競爭基準化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司簡介
    • Abbott Laboratories
    • Asahi Kasei Corporation
    • BIOTRONIK SE & Co. KG
    • Boston Scientific Corporation
    • Cardiac Science Corporation
    • CU Medical Systems, Inc.
    • Fukuda Denshi Co., Ltd.
    • Getinge Group
    • LivaNova PLC
    • Mediana Co. Ltd.
    • Medtronic plc
    • Metsis Medikal
    • MicroPort Scientific Corporation
    • Mindray Medical International
    • Nihon Kohden Corporation
    • Philips Healthcare
    • Progetti Srl
    • Schiller AG
    • Stryker Corporation
    • ZOLL Medical Corporation
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5645

Defibrillator Market size was valued at US$ 8,345.67 Million in 2024, expanding at a CAGR of 8.7% from 2025 to 2032.

A defibrillator is a medical device designed to deliver a controlled electric shock to the heart to restore a normal heartbeat. It is used in life-threatening situations such as ventricular fibrillation or pulseless ventricular tachycardia, where the heart's electrical activity becomes chaotic or stops effectively pumping blood. By sending a high-energy pulse through the chest wall to the heart, a defibrillator can reset the heart's rhythm, giving it a chance to resume normal contractions. These devices can be manual, used by trained medical professionals, or automated (AEDs), designed for use by laypersons in emergencies.

Defibrillator Market- Market Dynamics

Expansion of Emergency Medical Services with Defibrillator-Equipped Ambulances Improving Survival Rates

The rapid expansion of emergency medical services (EMS) globally is playing a pivotal role in improving cardiac arrest survival rates. In both urban and rural areas, the deployment of ambulances equipped with advanced defibrillation technology ensures immediate life-saving intervention before the patient reaches a hospital. Cardiac arrest survival rates are highly dependent on the speed of treatment every minute without defibrillation significantly reduces the chances of recovery. By integrating defibrillators into EMS fleets, emergency responders can initiate treatment within the critical "golden minutes," improving patient outcomes. Many countries are investing heavily in upgrading their EMS infrastructure. This includes not only expanding the number of ambulances in service but also ensuring each unit carries state-of-the-art automated external defibrillators (AEDs) or manual defibrillators. These devices are particularly crucial for rural or remote regions where hospital access is delayed.

Moreover, governments and health organizations are training EMS personnel extensively in advanced cardiac life support (ACLS) protocols, enabling them to operate defibrillators effectively and increase the success rate of resuscitation efforts. The integration of smart defibrillators with real-time patient monitoring and wireless data transfer is further enhancing EMS capabilities. Some advanced models transmit patient ECG data directly to hospital emergency departments, allowing doctors to prepare for immediate intervention upon arrival. This connectivity ensures a seamless handover between pre-hospital and in-hospital care, reducing treatment delays. As a result, EMS equipped with modern defibrillation systems is not only saving lives but also reducing the risk of long-term complications in cardiac patients.

For Instance,

In March 2024, The National Health Service (NHS) rolled out 300 newly built ambulances equipped with both advanced manual defibrillators and user-friendly automated external defibrillators (AEDs). This large-scale upgrade is part of a broader initiative to strengthen pre-hospital cardiac emergency care. The program specifically focuses on improving intervention times during sudden cardiac arrests, where survival rates drop rapidly without immediate defibrillation.

Defibrillator Market- Key Insights

As per the analysis shared by our research analyst, the global Defibrillator market is estimated to grow annually at a CAGR of around 8.7% over the forecast period (2025-2032).

Based on component segmentation, Implantable Cardioverter Defibrillators (ICDs) accounted for the largest market share in 2024.

Based on product type segmentation, S-ICD was the leading product type in 2024.

Based on end-user segmentation, Hospitals were the dominant end-user category in 2024.

Based on region, Asia Pacific was the leading revenue generator in 2024.

Defibrillator Market- Segmentation Analysis:

The Global Defibrillator Market is segmented based on by component, by product type, by end user and region.

The market is divided into two categories based on component type: implantable cardioverter defibrillators (ICDs), external defibrillators (ED). The implantable cardioverter defibrillators dominate the market driven by their effectiveness in continuous heart rhythm monitoring and automatic life-saving intervention for high-risk cardiac patients. ICDs are widely adopted in patients with a history of ventricular fibrillation, ventricular tachycardia, or those at significant risk of sudden cardiac arrest. Their capability to deliver precise electrical shocks inside the body without external intervention makes them a preferred choice among cardiologists and healthcare providers. Technological advancements, such as miniaturized devices, longer battery life, and improved remote monitoring, have further strengthened their adoption across hospitals and specialized cardiac care centers. The demand for ICDs is also supported by rising incidences of cardiovascular diseases, increasing awareness about preventive cardiac care, and favorable reimbursement policies in several countries. With ongoing innovations and expanding clinical applications, ICDs are expected to maintain their market leadership over the forecast period.

The market is divided into four categories based on end user type: hospital, public access market, alternate care market, home healthcare. The hospitals dominate the market primarily driven by its critical role in managing sudden cardiac arrest cases and other cardiovascular emergencies. Hospitals are equipped with advanced infrastructure, intensive care units, and skilled healthcare professionals, which ensures the effective use of defibrillators. A large patient inflow and the rising number of surgeries requiring cardiac monitoring further boost demand in this segment. Hospitals also adopt the latest defibrillation technologies, including automated and implantable devices, to improve patient outcomes. Government initiatives and investments in healthcare infrastructure strengthen their capacity to manage emergencies. Moreover, hospitals are often the first point of treatment during emergencies, making them a reliable end-user segment. As cardiovascular disease cases continue to rise globally, hospitals will remain the leading contributor to defibrillator adoption.

Defibrillator Market- Geographical Insights

Asia Pacific dominates the global defibrillator market during the forecast period in 2024.

Asia Pacific is projected to dominate the global defibrillator market during the forecast period in 2024, both in terms of revenue and market growth. The region's leadership is largely driven by the increasing prevalence of cardiovascular diseases, rising healthcare awareness, and the rapid expansion of healthcare infrastructure in countries such as China, India, Japan, and South Korea. Hospitals and specialized cardiac care centers in these countries are increasingly adopting Implantable Cardioverter Defibrillators (ICDs) and advanced External Defibrillators (EDs) to manage sudden cardiac arrest and other life-threatening conditions. The growing investments by governments and private healthcare providers in modernizing emergency medical services, including the deployment of defibrillator-equipped ambulances, have significantly enhanced accessibility and timely cardiac care. Additionally, large-scale public access defibrillation programs in urban centres, along with rising awareness of preventive cardiac care, are fuelling market expansion. Technological advancements such as miniaturized devices, wearable defibrillators, and remote monitoring systems are further driving adoption across hospitals, alternate care facilities, and home healthcare setups.

Moreover, the region benefits from a large patient pool, increasing disposable income, and supportive government initiatives for cardiovascular disease management, which collectively make Asia Pacific a highly attractive market for defibrillator manufacturers. These factors are expected to sustain the region's dominance in the global market throughout the forecast period.

North America is estimated to register the highest CAGR in the defibrillator market during the forecast period in 2024.

North America is estimated to register the highest compound annual growth rate (CAGR) in the global Defibrillator Market during the forecast period in 2024. This robust growth is driven by the region's well-established healthcare infrastructure, high awareness of cardiac care, and the widespread adoption of advanced defibrillation technologies. The United States and Canada, in particular, are witnessing increasing investments in hospitals, emergency medical services, and home healthcare solutions, which are accelerating the demand for both Implantable Cardioverter Defibrillators (ICDs) and External Defibrillators (EDs). The growth is further supported by large-scale public access defibrillation programs in schools, airports, sports facilities, and workplaces, improving response times for sudden cardiac arrests. Technological advancements such as automated and wearable defibrillators, enhanced battery life, and remote monitoring capabilities are also contributing to higher adoption rates among hospitals, alternate care facilities, and home healthcare users. Additionally, favorable reimbursement policies, insurance coverage for cardiac devices, and government initiatives to enhance pre-hospital emergency care are encouraging both healthcare providers and consumers to adopt defibrillation solutions. The combination of these factors, along with rising cardiovascular disease prevalence, positions North America as the fastest-growing market globally in terms of CAGR during the forecast period.

Defibrillator Market- Competitive Landscape:

The global defibrillator market is highly competitive, characterized by the presence of several established medical device manufacturers and innovative startups focused on advanced cardiac care solutions. Companies are competing based on technological innovation, product quality, geographical presence, and strategic partnerships. The competitive landscape is marked by frequent product launches, collaborations, mergers, and acquisitions aimed at strengthening market position and expanding regional reach. Key players are investing significantly in research and development to introduce next-generation defibrillators, including implantable cardioverter defibrillators (ICDs), wearable defibrillators, semi-automatic and automated external defibrillators (AEDs). These innovations focus on features such as miniaturization, longer battery life, enhanced patient monitoring, connectivity with mobile apps, and real-time ECG transmission. By incorporating these advanced features, manufacturers aim to improve user-friendliness and clinical efficacy, thereby differentiating their offerings in a crowded market. Geographically, companies are expanding operations in emerging markets such as Asia Pacific, Latin America, and the Middle East due to rising cardiovascular disease prevalence, growing healthcare expenditure, and government initiatives for pre-hospital cardiac care. Strategic partnerships with hospitals, EMS providers, and public access programs further help in increasing market penetration.

Additionally, the competitive environment encourages pricing strategies, after-sales services, and training programs to maintain customer loyalty and ensure the proper use of defibrillation devices. Regulatory compliance and approvals from agencies such as the FDA, CE, and other regional authorities also play a critical role in shaping the competitive landscape.

Recent Developments:

In January 2025, The Australian government committed AUD 50 million to upgrading its national ambulance fleet with portable defibrillators and advanced patient monitoring devices. These portable systems allow EMS personnel to initiate life-saving measures in route to hospitals, even in remote regions. The initiative is expected to significantly improve survival rates for out-of-hospital cardiac arrest cases, which account for thousands of preventable deaths annually.

In June 2024, Stryker launched the LIFEPAK 35 monitor/defibrillator, featuring advanced proprietary tools built on an intuitive, modern platform. The device is designed to provide healthcare professionals with rapid, accurate patient data during cardiac emergencies. Its integrated features, including real-time ECG monitoring and improved defibrillation algorithms, enhance the chances of successful resuscitation. The launch strengthens Stryker's portfolio in both hospital and pre-hospital emergency care markets.

In October 2024, MicroPort CRM received approval from China's National Medical Products Administration (NMPA) for the PLATINIUM implantable cardioverter defibrillator (ICD). This marks the first ICD manufactured domestically in China to gain regulatory clearance. The device provides continuous monitoring and automated shock delivery for patients at risk of sudden cardiac arrest. Its approval is expected to expand access to advanced cardiac care across hospitals and specialty clinics in China.

In October 2024, ZOLL announced that its AED Plus defibrillator received approval under the European Union Medical Device Regulation (EU MDR). This certification ensures full compliance with stringent European safety and performance standards, enabling wider distribution across EU countries. The AED Plus is designed for ease of use, rapid deployment, and improved survival outcomes in cardiac emergencies. By meeting EU MDR standards, ZOLL enhances its credibility and competitiveness in the European defibrillator market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DEFIBRILLATOR MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Asahi Kasei Corporation
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • CU Medical Systems, Inc.
  • Fukuda Denshi Co., Ltd.
  • Getinge Group
  • LivaNova PLC
  • Mediana Co. Ltd.
  • Medtronic plc
  • Metsis Medikal
  • MicroPort Scientific Corporation
  • Mindray Medical International
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Progetti Srl
  • Schiller AG
  • Stryker Corporation
  • ZOLL Medical Corporation
  • Others

GLOBAL DEFIBRILLATOR MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Implantable Cardioverter Defibrillators (ICDs)
  • External Defibrillators (ED)Front
  • Others

GLOBAL DEFIBRILLATOR MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • S-ICD
  • T-ICD
  • Manual ED
  • Automated ED
  • Wearable Cardioverter Defibrillators

GLOBAL DEFIBRILLATOR MARKET, BY END USERS- MARKET ANALYSIS, 2019 - 2032

  • Hospital
  • Public Access Market
  • Alternate Care Market
  • Home Healthcare

GLOBAL DEFIBRILLATOR MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Defibrillator Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Defibrillator Market Snippet by Component
    • 2.1.2. Defibrillator Market Snippet by Product Type
    • 2.1.3. Defibrillator Market Snippet by End User
    • 2.1.4. Defibrillator Market Snippet by Country
    • 2.1.5. Defibrillator Market Snippet by Region
  • 2.2. Competitive Insights

3. Defibrillator Key Market Trends

  • 3.1. Defibrillator Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Defibrillator Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Defibrillator Market Opportunities
  • 3.4. Defibrillator Market Future Trends

4. Defibrillator Industry Study

  • 4.1. PESTEL Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Defibrillator Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Defibrillator Market Landscape

  • 6.1. Defibrillator Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Defibrillator Market- By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 7.1.2. Implantable Cardioverter Defibrillators (ICDs)
    • 7.1.3. External Defibrillators (ED)

8. Defibrillator Market- By Product Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 8.1.2. S-ICD
    • 8.1.3. T-ICD
    • 8.1.4. Manual ED
    • 8.1.5. Automated ED
    • 8.1.6. Wearable Cardioverter Defibrillators

9. Defibrillator Market- By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospital
    • 9.1.3. Public Access Market
    • 9.1.4. Alternate Care Market
    • 9.1.5. Home Healthcare

10. Defibrillator Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Defibrillator Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Defibrillator Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Defibrillator Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Defibrillator Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Defibrillator Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Defibrillator Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Asahi Kasei Corporation
    • 11.2.3. BIOTRONIK SE & Co. KG
    • 11.2.4. Boston Scientific Corporation
    • 11.2.5. Cardiac Science Corporation
    • 11.2.6. CU Medical Systems, Inc.
    • 11.2.7. Fukuda Denshi Co., Ltd.
    • 11.2.8. Getinge Group
    • 11.2.9. LivaNova PLC
    • 11.2.10. Mediana Co. Ltd.
    • 11.2.11. Medtronic plc
    • 11.2.12. Metsis Medikal
    • 11.2.13. MicroPort Scientific Corporation
    • 11.2.14. Mindray Medical International
    • 11.2.15. Nihon Kohden Corporation
    • 11.2.16. Philips Healthcare
    • 11.2.17. Progetti Srl
    • 11.2.18. Schiller AG
    • 11.2.19. Stryker Corporation
    • 11.2.20. ZOLL Medical Corporation
    • 11.2.21. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us